VANI
Vivani Medical, Inc.
There isn't enough reported data to score VANI yet.
VANI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
VANI's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
VANI PE Valuation
VANI has no meaningful PE right now: it lost money over the past year.
VANI Forward outlook
There aren't enough analyst estimates for VANI to show an outlook.
VANI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.32 | +$0.12 |
| Q2 2026 | -$0.35 | +$0.09 |
| Q1 2026 | -$0.40 | +$0.02 |
| Q4 2025 | -$0.43 | $0.00 |
| Q3 2022 | -$0.46 | +$0.50 |
| Q2 2022 | -$0.68 | +$0.31 |
| Q1 2022 | -$0.68 | +$0.52 |
| Q4 2021 | -$0.87 | +$1.68 |
VANI is still losing money, but far less than before: $0.32 per share over the past year, against $7.02 at its worst in late 2019.
VANI Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2019 | -1635% | N/A |
VANI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.4M | +$784K |
| Q2 2026 | -$6.1M | +$24K |
| Q1 2026 | -$6.2M | -$1M |
| Q4 2025 | -$7M | -$885K |
| Q3 2025 | -$7.2M | -$1.5M |
| Q2 2025 | -$6.2M | -$1.3M |
| Q1 2025 | -$5.2M | -$474K |
| Q4 2024 | -$6.1M | -$1.9M |
VANI has burned cash in almost every quarter: −$26M over the past year, against −$25M the year before.
VANI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.5% | +3M shares |
| 1 year | +52% | +30.9M shares |
| 3 years | +586% | +77M shares |
| 5 years | +1738% | +85.2M shares |
VANI has 90M diluted shares, up 52% from a year ago.
VANI Net Leverage
VANI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VANI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 14.3 | Oversold |
VANI's weekly RSI is 36 (neutral) and its Stochastic is 14 (oversold).
VANI PE vs Healthcare Sector
VANI has no meaningful PE right now: it lost money over the past year.
VANI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.14 | 14% below |
| 20 week MA | $1.26 | 22% below |
| 50 week MA | $1.25 | 22% below |
| 100 week MA | $1.25 | 22% below |
| 200 week MA | $1.26 | 22% below |
VANI is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
VANI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.8 | $7.53 | -58% |
| 2021 | $7.53 | $5.79 | -23% |
| 2022 | $5.79 | $0.93 | -84% |
| 2023 | $0.93 | $1.02 | +9.7% |
| 2024 | $1.02 | $1.18 | +16% |
| 2025 | $1.18 | $1.27 | +7.6% |
| 2026 YTD | $1.27 | $0.98 | -23% |
VANI has finished lower in three of the last six years. It's down 23% so far in 2026.